Literature DB >> 19074838

EWS-Fli1 up-regulates expression of the Aurora A and Aurora B kinases.

Kazuhiko Wakahara1, Takatoshi Ohno, Masashi Kimura, Takahiro Masuda, Satoshi Nozawa, Taikoh Dohjima, Takatoshi Yamamoto, Akihito Nagano, Gou Kawai, Aya Matsuhashi, Mitsuru Saitoh, Iori Takigami, Yukio Okano, Katsuji Shimizu.   

Abstract

EWS-Fli1, a fusion gene resulting from the chromosomal translocation t(11;22, q24;q12), encodes a transcriptional activator, promotes cellular transformation, and is often found in Ewing sarcoma and primitive neuroectodermal tumor. The Aurora A and Aurora B kinases belong to a highly conserved family of serine/threonine protein kinases, are tightly regulated during the cell cycle, and are overexpressed in many carcinomas. Because the relationship between the Aurora A and/or Aurora B genes and the EWS-Fli1 fusion gene is unknown, we investigated the regulatory mechanism(s) by which Aurora kinases are controlled. Knockdown of EWS-Fli1 by small interfering RNA reduced mRNA levels not only of EWS-Fli1 but also of Aurora A and Aurora B. Luciferase assay using Aurora A and Aurora B promoters showed up-regulated activities compared with those of an empty vector. Experiments with deletion and point mutants showed positive regulatory Ets-binding sites located -84 and -71 bp upstream of the transcription initiation sites in Aurora A and Aurora B, respectively. Moreover, chromatin immunoprecipitation assay revealed that EWS-Fli1 gene products interact with both the Aurora A and Aurora B promoters. These results strongly suggest that the mitotic kinases Aurora A and Aurora B are regulated by EWS-Fli1 fusion protein in Ewing sarcoma cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19074838     DOI: 10.1158/1541-7786.MCR-08-0054

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  30 in total

Review 1.  Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma.

Authors:  Hayriye V Erkizan; Vladimir N Uversky; Jeffrey A Toretsky
Journal:  Clin Cancer Res       Date:  2010-06-14       Impact factor: 12.531

2.  Ewing sarcoma EWS protein regulates midzone formation by recruiting Aurora B kinase to the midzone.

Authors:  Hyewon Park; Timothy K Turkalo; Kayla Nelson; Stephen Sai Folmsbee; Caroline Robb; Brittany Roper; Mizuki Azuma
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

3.  High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma.

Authors:  Sarah Wang; Elizabeth E Hwang; Rajarshi Guha; Allison F O'Neill; Nicole Melong; Chansey J Veinotte; Amy Conway Saur; Kellsey Wuerthele; Min Shen; Crystal McKnight; Gabriela Alexe; Madeleine E Lemieux; Amy Wang; Emma Hughes; Xin Xu; Matthew B Boxer; Matthew D Hall; Andrew Kung; Jason N Berman; Mindy I Davis; Kimberly Stegmaier; Brian D Crompton
Journal:  Clin Cancer Res       Date:  2019-04-12       Impact factor: 12.531

4.  Estrogen-induced aurora kinase-A (AURKA) gene expression is activated by GATA-3 in estrogen receptor-positive breast cancer cells.

Authors:  Shoulei Jiang; Hiroshi Katayama; Jin Wang; Sara Antonia Li; Yan Hong; Laszlo Radvanyi; Jonathan J Li; Subrata Sen
Journal:  Horm Cancer       Date:  2010-02-20       Impact factor: 3.869

Review 5.  Targeted therapies for advanced Ewing sarcoma family of tumors.

Authors:  Yunyun Jiang; Joseph Ludwig; Filip Janku
Journal:  Cancer Treat Rev       Date:  2015-03-27       Impact factor: 12.111

6.  Downstream EWS/FLI1 - upstream Ewing's sarcoma.

Authors:  Heinrich Kovar
Journal:  Genome Med       Date:  2010-01-28       Impact factor: 11.117

7.  RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma.

Authors:  Shilpi Arora; Irma M Gonzales; R Tanner Hagelstrom; Christian Beaudry; Ashish Choudhary; Chao Sima; Raoul Tibes; Spyro Mousses; David O Azorsa
Journal:  Mol Cancer       Date:  2010-08-18       Impact factor: 27.401

8.  Cell Cycle Deregulation in Ewing's Sarcoma Pathogenesis.

Authors:  Ashley A Kowalewski; R Lor Randall; Stephen L Lessnick
Journal:  Sarcoma       Date:  2010-11-01

9.  High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition.

Authors:  Ola Awad; Jason T Yustein; Preeti Shah; Naheed Gul; Varalakshmi Katuri; Alison O'Neill; Yali Kong; Milton L Brown; Jeffrey A Toretsky; David M Loeb
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

10.  EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases.

Authors:  Hem Chandra Jha; Jie Lu; Abhik Saha; Qiliang Cai; Shuvomoy Banerjee; Mahadesh A J Prasad; Erle S Robertson
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.